Aldeyra Therapeutics, Inc.
SEC Filing List
ALDX CIK: 0001341235
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Aldeyra Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Brady Todd C | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/31/2026 | |
| SCHEDULE 13G/A | 03/26/2026 | ||||
| SCHEDULE 13G/A | 03/26/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Douglas Richard | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/20/2026 | |
| 4 | Statement of changes in beneficial owner... | Alfieri Michael | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/19/2026 | |
| 8-K | Current report filing | Aldeyra Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/17/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Aldeyra Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/27/2026 | |
| S-8 | Initial registration statement for secur... | Aldeyra Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/27/2026 | |
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/17/2026 | |||
| No record found. | |||||
| Load More | |||||
